Boulet Sheree L, Stanhope Kaitlyn K, DeSantis Carol, Goebel Anna, Dolak Julia, Eze Onyie, Gathoo Asmita, Braun Caroline, Sutton Madeline, Jamieson Denise J
Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, Georgia, USA.
Womens Health Rep (New Rochelle). 2023 Jun 6;4(1):288-297. doi: 10.1089/whr.2023.0032. eCollection 2023.
To estimate uptake of influenza, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap), and COVID-19 vaccines during pregnancy and describe vaccine attitudes and beliefs among predominantly racial and ethnic minority individuals delivering at a publicly funded hospital.
We collected survey and electronic medical record data for English-speaking postpartum individuals who delivered a live-born infant from July 7, 2022, through August 21, 2022, and agreed to participate in our study. The 58-item survey included questions about general vaccine attitudes and beliefs as well as vaccine-specific questions. We calculated rates of influenza, Tdap, and COVID-19 vaccinations and compared distributions of survey responses by number (no vaccines, one vaccine, or two or three of the recommended vaccines) and type of vaccines received during pregnancy.
Of the 231 eligible individuals, 125 (54.1%) agreed to participate. Rates of influenza, Tdap, and COVID-19 vaccination were 18.4%, 48.0%, and 5.6% respectively. A total of 61 (48.8%) did not receive any recommended vaccines during pregnancy, 40 (32.0%) received one vaccine, and 24 (19.0%) received two or three vaccines. Approximately 66.1% of the no vaccine group, 81.6% of the one vaccine group, and 87.5% of the two or three vaccine group strongly agreed or agreed that they trusted the vaccine information provided by their obstetrician or midwife. While most (>69.2%) agreed that the vaccine-preventable diseases were dangerous for pregnant women, only 24.0%, 29.3%, and 40.3% agreed that they were worried about getting influenza, whooping cough, or COVID-19, respectively, while pregnant.
Vaccine uptake in our population was low and may be due, in part, to low perceived susceptibility to vaccine-preventable diseases. Obstetricians and midwives were trusted sources of vaccine information, suggesting that enhanced communication strategies could be critical for addressing maternal vaccine hesitancy, particularly in communities of color justifiably affected by medical mistrust.
评估流感、破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗（Tdap）以及新冠疫苗在孕期的接种情况，并描述在一家公立资助医院分娩的主要为少数种族和族裔个体的疫苗态度和信念。
我们收集了2022年7月7日至2022年8月21日期间分娩活产婴儿且同意参与我们研究的讲英语的产后个体的调查和电子病历数据。这份包含58个条目的调查问卷包括有关一般疫苗态度和信念以及特定疫苗的问题。我们计算了流感、Tdap和新冠疫苗的接种率，并按数量（未接种疫苗、接种一种疫苗或接种两种或三种推荐疫苗）和孕期接种的疫苗类型比较了调查回复的分布情况。
在231名符合条件的个体中，125名（54.1%）同意参与。流感、Tdap和新冠疫苗的接种率分别为18.4%、48.0%和5.6%。共有61名（48.8%）在孕期未接种任何推荐疫苗，40名（32.0%）接种了一种疫苗，24名（19.0%）接种了两种或三种疫苗。未接种疫苗组中约66.1%、接种一种疫苗组中81.6%以及接种两种或三种疫苗组中87.5%的人强烈同意或同意他们信任产科医生或助产士提供的疫苗信息。虽然大多数人（>69.2%）同意疫苗可预防疾病对孕妇有危险，但只有24.0%、29.3%和40.3%的人分别同意他们担心在孕期感染流感、百日咳或新冠。
我们人群中的疫苗接种率较低，部分原因可能是对疫苗可预防疾病的感知易感性较低。产科医生和助产士是受信任的疫苗信息来源，表示加强沟通策略对于解决产妇疫苗犹豫问题可能至关重要，特别是在因医疗不信任而受到合理影响的有色人种社区。
